Suchergebnisse

Vortrag (59)

281.
Vortrag
Henning, A.: Prescan for MRS: what, how, and potential sources of artifacts. 2nd TRANSACT Workshop: Quality Assurance in Clinical MR Spectroscopy, Bern, Switzerland (2014)
282.
Vortrag
Henning, A.: Ultra high field MRS and MRI. Technical University of Denmark, Lyngby, Denmark (2013)
283.
Vortrag
Henning, A.: Desired Ultra High Field B0 shim system specs: a static and dynamic shim perspective. 4th Ultra High Field (UHF) User Meeting: Siemens Healthcare, Wien, Austria (2013)
284.
Vortrag
Henning, A.: High Field Metabolic Imaging: from system architecture to application. Medical Physics Seminary: Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany (2013)
285.
Vortrag
Henning, A.: MR Spectroscopic Imaging in Oncology. Biomedica 2013: The 7th European Life Sciences Summit, Aachen, Germany (2013)
286.
Vortrag
Scheidegger, M.; Fuchs A, Lehmann M, Grimm S, Boeker H, Seifritz, E.; Henning, A.: Effect of an antidepressant dose of Ketamine on prefrontal aspartate, glutamine and GABA levels in healthy subjects: assessing the post-infusion interval with 1H MRS. 21st Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2013), Salt Lake City, UT, USA (2013)
287.
Vortrag
Henning, A.: Ultra-high field human MRI and MRS. Danish Research Centre for Magnetic Resonance (DRCMR), Copenhagen, Denmark (2013)
288.
Vortrag
Henning, A.: High Resolution 1H MRS Imaging. ISMRM Scientific Workshop on Ultra High Field MRI: What is in Full Bloom & What is Sprouting?, Noordwijk aan Zee, The Netherlands (2013)
289.
Vortrag
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. MRI Seminar: University of Texas South West, Dallas, TX, USA (2012)
290.
Vortrag
Henning, A.: MultiTX and Dynamic B0 Shim Updating. Philips Medical Systems: 7T User Meeting, Columbus, OH, USA (2012)
291.
Vortrag
Scheidegger, M.; Walter, M.; Lehmann, M.; Metzger, C.; Grimm, S.; Boeker, H.; Boesiger, P.; Henning, A.; Seifritz, E.: Ketamine decreases resting state functional connectivity between networks via the dorsal nexus: implications for major depression. Third Biennial Conference on Resting State Brain Connectivity, Magdeburg, Germany (2012)
292.
Vortrag
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Research Seminar GE Global Research, München, Germany (2012)
293.
Vortrag
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Maastricht University, Maastricht, The Netherlands (2012)
294.
Vortrag
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Cardiology Seminar: University of Aberdeen, Aberdeen, UK (2012)
295.
Vortrag
Henning, A.: In vivo NMR spectroscopy at ultra-high field: chances and challenges. XIXth Swiss NMR Symposium 2012 , Bern, Switzerland (2012)
296.
Vortrag
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Research Seminar: Max-Planck-Institut für Biologische Kybernetik, Tübingen, Germany (2011)
297.
Vortrag
Henning, A.: In vivo MRS at high and ultra-high fields. CIBM HUG Seminar: University of Geneva, Geneva, Switzerland (2010)
298.
Vortrag
Henning, A.: Ongoing spectroscopy projects, Philips Medical Systems. Philips Medical Systems: 7T User Meeting, Noordwijk, The Netherlands (2010)
299.
Vortrag
Henning, A.: Advances in MR spectroscopy at higher fields and applications of glutamatergic and GABAergic imaging in neurological and psychiatric diseases. SFB 779 Colloquium: Otto-von-Guericke-Universität, Magdeburg, Germany (2009)
300.
Vortrag
Henning, A.: MRS and MRI at high and ultra-high field. 7T User Group Colloquium: Vanderbuilt University, Nashville, TN, USA (2009)
Zur Redakteursansicht